ZBIOZBIONASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | -100.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | -100.20% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +9.06% | +9.09% | +9.26% | +0.91% | +11.26% |
| Weighted Average Shares Diluted Growth | +9.06% | +9.09% | +9.26% | +0.91% | +11.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +442.63% | +580.45% | +46.58% | -20.18% | +3.70% |
| Book Value per Share Growth | +0.00% | +0.00% | +36.37% | -45.84% | -30.34% |
| Debt Growth | -95.25% | -94.34% | +98.43% | +107.81% | +32.20% |
| R&D Expense Growth | +140.75% | +54.18% | +27.27% | +2.60% | +13.35% |
| SG&A Expenses Growth | +162.92% | +151.67% | +105.87% | +76.79% | +35.90% |